查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1782001

抗菌素抗药性诊断市场（依产品类型、病原体类型、技术、最终用途、国家和地区）－2025 年至 2032 年全球产业分析、市场规模、市场份额及预测

Antimicrobial Resistance Diagnostics Market, By Product Type, By Pathogen Type, By Technology, By End Use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 288 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告重点

2024 年抗菌素抗药性诊断市场规模价值 46.1022 亿美元，2025 年至 2032 年的复合年增长率为 6.90%。

抗菌素抗药性诊断市场-市场动态

更多采用快速和即时诊断技术，以便及时做出治疗决策

快速即时诊断技术 (POC) 在对抗抗生素抗药性方面发挥着至关重要的作用，它使医护人员能够快速识别抗药性感染并相应地制定治疗方案。与可能需要数天时间的传统实验室检测不同，这些先进的诊断技术可在数分钟或数小时内提供结果，有助于防止抗生素的过度使用和滥用。

根据世界卫生组织 (WHO) 2023 年的报告，快速诊断技术的应用已被证明可减少高达 30-40% 的不必要抗生素处方，显着抑制抗药性的产生。此外，更快、更准确的检测有助于及时进行针对性治疗，减少住院时间，并抑制医疗机构内感染的传播，从而改善患者预后。便携式即时诊断 (POC) 设备的日益普及也确保即使在偏远和资源有限的环境中也能获得关键的诊断能力，从而支持全球遏制抗菌素抗药性的努力。

例如，

2025年3月，雅培实验室推出了一款新型快速分子诊断检测，能够在一小时内检测出多种抗菌素抗药性病原体。此检测能够快速识别和隔离抗药性感染，从而加强医院感染控制，改善病患管理和抗生素管理。

抗菌素抗药性诊断市场—关键见解

根据我们的研究分析师的分析，预测期内（2025-2032 年）全球市场预计年复合成长率约为 6.90%

根据产品类型细分，预计试剂和耗材将在 2024 年占据最大市场份额

根据病原体类型细分，耐甲氧西林金黄色葡萄球菌 (MRSA) 是 2024 年的主要病原体类型

根据技术细分，聚合酶炼式反应（PCR）是2024年的领先技术

根据最终用途细分，医院是 2024 年的主要最终用途

按地区划分，北美是 2024 年的主要收入来源

抗菌素抗药性诊断市场-細項分析：

全球抗菌素抗药性诊断市场根据产品类型、病原体类型、技术、最终用途和地区进行细分。

依产品类型，市场分为两类：试剂耗材和仪器。试剂耗材领域占据市场主导地位。这些组件对于检测过程至关重要，不像仪器那样可能偶尔才购买。每项诊断测试都需要试剂耗材，这意味着持续可靠的需求。医疗机构和实验室始终在寻找补充供应，以确保其检测操作顺利进行。试剂耗材适用于不同的诊断平台，包括分子诊断、免疫测定和培养为基础的方法。这种广泛的兼容性增加了它们在各种检测环境中的使用。因此，医院、诊断实验室和即时诊断机构始终需要这些产品。诊断领域的新技术通常会催生针对特定测试的新型试剂，进一步促进市场成长。试剂耗材的定价模式对製造商有利，因为耗材能带来稳定的收入，而仪器的销售频率则较低。

根据最终用途，市场可分为五类：医院、诊断实验室、製药和生物技术公司、研究机构及其他。医院业占据市场主导地位，这源于医院是主要的医疗机构，经常诊断和治疗感染。由于医院内感染风险高，且迫切需要控制抗菌药物抗药性，医院在先进的诊断工具方面投入大量资金，以确保及时准确地检测抗药性病原体。此外，医院通常拥有实施先进抗菌药物抗药性诊断的基础设施、训练有素的人员和资金，从而推动了巨大的需求。医院在感染控制项目和抗生素管理中发挥的作用进一步凸显了其作为该市场关键最终用户的重要性。

抗菌素抗药性诊断市场—地理洞察

北美在全球抗菌素抗药性诊断市场占据主导地位，2024 年市占率为 45.71%。

北美仍是抗菌抗药性诊断领域规模最大、最成熟的市场，得益于其先进的医疗基础设施、广泛的研发活动以及高昂的医疗支出。领先的诊断公司、全面的抗菌药物管理计画以及政府支持的措施（例如美国国家抗击抗生素抗药性细菌行动计画）加速了先进诊断工具的普及。该地区的医院和临床实验室优先考虑早期准确检测抗药性病原体，以改善患者预后并减少院内感染。此外，强有力的报销框架和监管支持鼓励对创新诊断技术的投资，从而进一步推动市场成长。

预计在 2024 年预测期内，亚太地区抗菌素抗药性诊断市场的复合年增长率最高。

同时，亚太地区是成长最快的市场，这得益于人口快速成长、城市化进程加快以及抗药性菌株感染率上升等一系列因素的共同作用。中国、印度、日本和韩国等国正显着改善医疗基础设施，更加重视传染病的管理和诊断能力。该地区各国政府正在积极进行宣传活动，并实施监测和控制抗菌药物抗药性的政策，这刺激了对快速且经济高效的诊断解决方案的需求。此外，中产阶级人口的不断增长以及医疗设施可近性的改善，使得寻求及时诊断和治疗的患者群体更加庞大。多重抗药性细菌感染盛行率的上升、医疗资金的增加以及本地和国际诊断公司之间的合作，这些因素共同构成了亚太地区未来十年成长前景强劲、潜力巨大的市场。

抗菌素抗药性诊断市场-竞争格局：

抗菌素抗药性 (AMR) 诊断市场竞争激烈，多家全球和地区企业专注于创新、策略合作和产品发布，以巩固其市场地位。领先的公司在研发方面投入巨资，旨在推出快速、准确且经济高效的诊断解决方案，以满足日益增长的及时检测抗药性病原体的需求。

市场的主要参与者包括罗氏诊断、雅培实验室、生物梅里埃、丹纳赫集团（Cepheid）、凯杰和赛默飞世尔科技。这些公司利用其广泛的产品组合和强大的分销网络来保持竞争优势。他们还与医疗机构和政府合作，以扩大市场覆盖范围并支持抗菌药物抗药性监测计画。

该市场以频繁的技术进步为标誌，例如多重分子检测和即时检测平台的开发，这些技术能够提供更快、更精确的结果。此外，併购也是增强能力和进入新市场的常用策略。总而言之，竞争推动持续创新，确保在对抗抗菌素抗药性的斗争中，获得更高的诊断准确性和患者治疗效果。

最新动态：

2025年3月，生物梅里埃VITEK COMPACT PRO获得FDA 510(k)认证，这是一款结合微生物鑑定和抗生素敏感性测试的新一代系统。该系统的推出增强了临床实验室快速检测抗药性病原体的能力，从而支持针对性治疗，并改善患者管理，共同对抗抗菌药物抗药性。

2024年7月，凯杰宣布与一家全球医疗保健提供者合作，在区域诊所部署其QIAstat-Dx分析仪，用于快速抗菌药物抗药性诊断。此次合作旨在提高传统医院环境之外快速且准确的抗药性检测的可近性，支持早期介入。

2024年9月，赛默飞世尔科技推出了一款基于PCR的新型诊断试剂盒，旨在快速检测医院环境中的抗菌药物抗药性病原体。这项创新技术能够提供快速、准确的检测方法，这对于有效的抗生素管理至关重要，从而巩固了赛默飞世尔科技在抗菌药物抗药性诊断领域的地位。

2022年7月，领先的研发驱动生物製药公司勃林格殷格翰与生命科学公司Evotec SE和生物梅里埃宣布成立合资企业，共同开发下一代抗菌药物和可操作的诊断方法，以对抗抗菌药物抗药性。此次合作有助于该公司拓展其抗菌药物抗药性诊断产品线。

目录

第一章：抗菌素抗药性诊断市场概述

  • 研究范围
  • 市场估计年限

第二章：执行摘要

  • 市场片段
    • 抗菌素抗药性诊断市场片段（按产品类型）
    • 抗菌素抗药性诊断市场片段（按病原体类型）
    • 抗菌素抗药性诊断市场（按技术）
    • 抗菌素抗药性诊断市场片段（依最终用途）
    • 抗菌素抗药性诊断市场（按国家/地区）
    • 抗菌素抗药性诊断市场（按地区）
  • 竞争洞察

第三章：抗菌素抗药性诊断关键市场趋势

  • 抗菌素抗药性诊断市场驱动因素
    • 市场驱动因素的影响分析
  • 抗菌素抗药性诊断市场限制
    • 市场限制的影响分析
  • 抗菌素抗药性诊断市场机会
  • 抗菌素抗药性诊断市场未来趋势

第四章：抗菌素抗药性诊断产业研究

  • PESTEL分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第五章：抗菌素抗药性诊断市场：地缘政治紧张局势升级的影响

  • COVID-19 疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：抗菌素抗药性诊断市场格局

  • 2024年抗菌素抗药性诊断市场占有率分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第七章：抗菌素抗药性诊断市场－依产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 试剂和耗材
    • 仪器

第 8 章：抗菌素抗药性诊断市场 - 按病原体类型

  • 概述
    • 按病原体类型分類的细分份额分析
    • 艰难梭菌（CD）
    • 抗药性弯曲桿菌（DRC）
    • 抗药性淋病奈瑟菌（DRNG）
    • 抗药性肺炎链球菌 (DRSP)
    • 抗甲氧西林金黄色葡萄球菌（MRSA）
    • 其他病原体类型

第九章：抗菌素抗药性诊断市场－依技术分类

  • 概述
    • 按技术细分的市场份额分析
    • 免疫测定
    • 质谱法
    • 微生物培养
    • 下一代定序（NGS）
    • 聚合酶炼式反应（PCR）
    • 快速和护理点
    • 其他技术

第 10 章：抗菌素抗药性诊断市场 - 按最终用途

  • 概述
    • 按最终用途分類的细分市场份额分析
    • 诊断实验室
    • 医院
    • 製药和生物技术公司
    • 研究机构
    • 其他的

第 11 章：抗菌素抗药性诊断市场 - 按地理划分

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美抗菌素抗药性诊断主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模及预测（按病原体类型）
    • 北美市场规模和预测（按技术）
    • 北美市场规模和预测，按最终用途
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲抗菌素抗药性诊断主要製造商
    • 欧洲市场规模及预测（按国家/地区）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模及预测（按病原体类型）
    • 欧洲市场规模与预测（按技术）
    • 欧洲市场规模和预测，按最终用途
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区抗菌素抗药性诊断主要製造商
    • 亚太地区市场规模及预测（依国家）
    • 亚太地区市场规模及预测（依产品类型）
    • 亚太地区市场规模及预测（依病原体类型）
    • 亚太地区市场规模及预测（依技术）
    • 亚太地区市场规模及预测（依最终用途）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲抗菌素抗药性诊断主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（依产品类型）
    • 拉丁美洲市场规模及预测（按病原体类型）
    • 拉丁美洲市场规模及预测（按技术）
    • 拉丁美洲市场规模及预测（依最终用途）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲（MEA）
    • 概述
    • 中东和非洲抗菌素抗药性诊断主要製造商
    • MEA 市场规模及预测（依国家/地区）
    • MEA 市场规模及预测（依产品类型）
    • MEA 市场规模及预测（依病原体类型）
    • MEA 市场规模及预测（依技术）
    • MEA 市场规模及预测（依最终用途）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其余地区

第 12 章：主要供应商分析-抗菌素抗药性诊断产业

  • 竞争基准化分析
    • Competitive Dashboard
    • Competitive Positioning
  • 公司简介
    • Abbott Laboratories
    • Accelerated Diagnostics, USA
    • Alifax
    • BD
    • Beckman Coulter
    • Becton, Dickinson and Company
    • BioMerieux
    • Bio-Rad Laboratories
    • Danaher
    • F. Hoffmann-La Roche
    • GeneFluidics
    • Hologic, Inc.
    • Molsid
    • OpGen
    • Roche Diagnostics
    • Thermo Fisher Scientific
    • Vela Diagnostics
    • Visby Medical, Inc.
    • Others

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV5383

REPORT HIGHLIGHT

Antimicrobial Resistance Diagnostics Market size was valued at US$ 4,610.22 Million in 2024, expanding at a CAGR of 6.90% from 2025 to 2032.

The Antimicrobial Resistance (AMR) Diagnostics Market is the global industry that focuses on developing, producing, and selling diagnostic tools and technologies to detect antimicrobial-resistant pathogens. These diagnostics help identify resistance patterns in bacteria, viruses, fungi, and parasites. This information allows healthcare providers to prescribe effective treatments and prevent inappropriate use of antimicrobials. The market includes molecular diagnostics, immunoassays, microbiology techniques, and rapid point of care tests used in clinical, hospital, and research settings. As antimicrobial resistance rises worldwide and becomes a serious public health threat, the demand for timely and accurate AMR diagnostics is increasing significantly. This growth is driving innovation and investment in the field.

Antimicrobial Resistance Diagnostics Market- Market Dynamics

Increased adoption of rapid and point-of-care diagnostic technologies to enable timely treatment decisions

Rapid and point-of-care (POC) diagnostic technologies play a crucial role in combating antimicrobial resistance by enabling healthcare professionals to quickly identify resistant infections and tailor treatments accordingly. Unlike conventional laboratory tests that may take days, these advanced diagnostics provide results within minutes or hours, which helps prevent the overuse and misuse of antibiotics.

According to a 2023 World Health Organization (WHO) report, the use of rapid diagnostics has been shown to reduce unnecessary antibiotic prescriptions by up to 30-40%, significantly limiting the development of resistance. Additionally, faster and more accurate detection improves patient outcomes by facilitating timely, targeted therapies, reducing hospital stays, and curbing the spread of infections in healthcare facilities. The increasing availability of portable POC devices also ensures that even remote and resource-limited settings can access critical diagnostic capabilities, bolstering global efforts to contain antimicrobial resistance.

For Instance,

In March 2025, Abbott Laboratories launched a new rapid molecular diagnostic test capable of detecting multiple antimicrobial-resistant pathogens within an hour. This test enhances hospital infection control by enabling quick identification and isolation of resistant infections, improving patient management and antibiotic stewardship.

Antimicrobial Resistance Diagnostics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.90% over the forecast period (2025-2032)

Based on product type segmentation, reagents & consumables was predicted to show maximum market share in the year 2024

Based on pathogen type segmentation, methicillin-resistant staphylococcus aureus (MRSA) was the leading pathogen type in 2024

Based on technology segmentation, polymerase chain reaction (PCR) was the leading technology in 2024

Based on end use segmentation, hospitals was the leading end use in 2024

On the basis of region, North America was the leading revenue generator in 2024

Antimicrobial Resistance Diagnostics Market- Segmentation Analysis:

The global antimicrobial resistance diagnostics market is segmented on the basis of product type, pathogen type, technology, end use and region.

The market is divided into two categories based on product type: reagents & consumables and instruments. The reagents & consumables sector dominates the market. These components are essential for the testing process, unlike instruments that you might only buy once in a while. Reagents and consumables are needed for every single diagnostic test, which means there's a constant and reliable demand. Healthcare facilities and labs are always on the lookout to restock their supplies to keep their testing operations running smoothly. Reagents and consumables work well with different diagnostic platforms, including molecular diagnostics, immunoassays, and culture-based methods. This broad compatibility increases their use in various testing environments. As a result, hospitals, diagnostic labs, and point-of-care facilities consistently need these products. New technology in diagnostics often results in the creation of new reagents designed for specific tests, which grows the market even more. The pricing models for reagents and consumables benefit manufacturers since consumables provide steady revenue, unlike the less frequent sales of instruments.

The market is divided into five categories based on end-use: hospitals, diagnostic laboratories, pharmaceutical & biotechnology companies, research institutes and others. The hospitals sector dominates the market and this dominance stems from hospitals being the primary points of care where infections are frequently diagnosed and treated. Due to the high risk of hospital-acquired infections and the critical need to manage antimicrobial resistance, hospitals invest heavily in advanced diagnostic tools to ensure timely and accurate detection of resistant pathogens. Moreover, hospitals often have the infrastructure, trained personnel, and funding to implement sophisticated AMR diagnostics, driving substantial demand. Their role in infection control programs and antibiotic stewardship further underscores their importance as a key end user in this market.

Antimicrobial Resistance Diagnostics Market- Geographical Insights

North America dominates the global antimicrobial resistance diagnostics market, holding a 45.71% market share in 2024.

North America remains the largest and most mature market for antimicrobial resistance diagnostics, supported by advanced healthcare infrastructure, extensive research and development activities, and high healthcare spending. The presence of leading diagnostic companies, coupled with comprehensive antimicrobial stewardship programs and government-backed initiatives such as the U.S. National Action Plan for Combating Antibiotic-Resistant Bacteria, has accelerated the adoption of sophisticated diagnostic tools. Hospitals and clinical laboratories in this region prioritize early and accurate detection of resistant pathogens to improve patient outcomes and reduce healthcare-associated infections. Additionally, strong reimbursement frameworks and regulatory support further drive market growth by encouraging investment in innovative diagnostics.

Asia Pacific is estimated to register the highest CAGR in the antimicrobial resistance diagnostics market during the forecast period in 2024.

The Asia-Pacific region, meanwhile, is the fastest-growing market due to a confluence of factors including a rapidly expanding population, increasing urbanization, and rising incidence of infectious diseases with resistant strains. Countries such as China, India, Japan, and South Korea are experiencing significant improvements in healthcare infrastructure, with increased focus on infectious disease management and diagnostic capacity. Governments in the region are actively launching awareness campaigns and implementing policies to monitor and control AMR, which boost demand for rapid and cost effective diagnostic solutions. Moreover, the growing middle class population and improved access to healthcare facilities create a larger patient base seeking timely diagnosis and treatment. The combination of rising prevalence of multidrug-resistant infections, greater healthcare funding, and partnerships between local and international diagnostic firms positions Asia-Pacific as a high-potential market with robust growth prospects over the coming decade.

Antimicrobial Resistance Diagnostics Market- Competitive Landscape:

The antimicrobial resistance (AMR) diagnostics market features a competitive landscape characterized by the presence of several global and regional players focusing on innovation, strategic collaborations, and product launches to strengthen their market position. Leading companies invest heavily in research and development to introduce rapid, accurate, and cost-effective diagnostic solutions that cater to the growing demand for timely detection of resistant pathogens.

Key players in the market include Roche Diagnostics, Abbott Laboratories, bioMerieux, Danaher Corporation (Cepheid), QIAGEN, and Thermo Fisher Scientific. These companies leverage their extensive product portfolios and strong distribution networks to maintain a competitive edge. They also engage in partnerships with healthcare institutions and governments to expand their market reach and support AMR surveillance programs.

The market is marked by frequent technological advancements such as the development of multiplex molecular assays and point of care testing platforms, which provide faster and more precise results. Additionally, mergers and acquisitions are common strategies employed to enhance capabilities and enter new markets. Overall, competition drives continuous innovation, ensuring better diagnostic accuracy and patient outcomes in the fight against antimicrobial resistance.

Recent Developments:

In March 2025, bioMerieux received FDA 510(k) clearance for its VITEK COMPACT PRO, a next-generation system combining microorganism identification and antibiotic susceptibility testing. This launch enhances clinical labs' capabilities to rapidly detect resistant pathogens, thereby supporting targeted treatments and improving patient management in the fight against AMR

In July 2024, QIAGEN announced a collaboration with a global healthcare provider to deploy its QIAstat-Dx Analyzer in regional clinics for rapid AMR diagnostics. This partnership aims to improve access to quick and accurate resistance testing outside traditional hospital settings, supporting early intervention

In September 2024, Thermo Fisher Scientific launched a new PCR-based diagnostic kit designed to rapidly detect antimicrobial-resistant pathogens in hospital settings. This innovation strengthens Thermo Fisher's position in the AMR diagnostics space by offering fast, accurate testing critical for effective antibiotic stewardship

In July 2022, Boehringer Ingelheim, a leading research-driven biopharmaceutical company, along with the life sciences company Evotec SE and bioMerieux, announced a joint venture to develop the next generation of antimicrobials and actionable diagnostics to combat AMR. This collaboration helped the company broaden its product offerings for AMR diagnosis

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • Accelerated Diagnostics, USA
  • Alifax
  • BD
  • Beckman Coulter
  • Becton, Dickinson and Company
  • BioMerieux
  • Bio-Rad Laboratories
  • Danaher
  • F. Hoffmann-La Roche
  • GeneFluidics
  • Hologic, Inc.
  • Molsid
  • OpGen
  • Roche Diagnostics
  • Thermo Fisher Scientific
  • Vela Diagnostics
  • Visby Medical, Inc.
  • Others

GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Reagents & Consumables
  • Instruments

GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTICS MARKET, BY PATHOGEN TYPE- MARKET ANALYSIS, 2019 - 2032

  • Clostridium difficile (CD)
  • Drug-resistant campylobacter (DRC)
  • Drug-resistant Neisseria gonorrhoeae (DRNG)
  • Drug-resistant streptococcus pneumoniae (DRSP)
  • Methicillin-resistant Staphylococcus aureus (MRSA)
  • Other pathogen types

GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTICS MARKET, BY TECHNOLOGY - MARKET ANALYSIS, 2019 - 2032

  • Immunoassay
  • Mass spectrometry
  • Microbiology culture
  • Next generation sequencing (NGS)
  • Polymerase chain reaction (PCR)
  • Rapid & point of care
  • Other technologies

GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTICS MARKET, BY END USE - MARKET ANALYSIS, 2019 - 2032

  • Diagnostic Laboratories
  • Hospitals
  • Pharmaceutical & Biotechnology Companies
  • Research Institutes
  • Others

GLOBAL ANTIMICROBIAL RESISTANCE DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Antimicrobial Resistance Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Antimicrobial Resistance Diagnostics Market Snippet by Product Type
    • 2.1.2. Antimicrobial Resistance Diagnostics Market Snippet by Pathogen Type
    • 2.1.3. Antimicrobial Resistance Diagnostics Market Snippet by Technology
    • 2.1.4. Antimicrobial Resistance Diagnostics Market Snippet by End Use
    • 2.1.5. Antimicrobial Resistance Diagnostics Market Snippet by Country
    • 2.1.6. Antimicrobial Resistance Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. Antimicrobial Resistance Diagnostics Key Market Trends

  • 3.1. Antimicrobial Resistance Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Antimicrobial Resistance Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Antimicrobial Resistance Diagnostics Market Opportunities
  • 3.4. Antimicrobial Resistance Diagnostics Market Future Trends

4. Antimicrobial Resistance Diagnostics Industry Study

  • 4.1. PESTEL Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Antimicrobial Resistance Diagnostics Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Antimicrobial Resistance Diagnostics Market Landscape

  • 6.1. Antimicrobial Resistance Diagnostics Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Antimicrobial Resistance Diagnostics Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Reagents & Consumables
    • 7.1.3. Instruments

8. Antimicrobial Resistance Diagnostics Market - By Pathogen Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Pathogen Type, 2024 & 2032 (%)
    • 8.1.2. Clostridium difficile (CD)
    • 8.1.3. Drug-resistant campylobacter (DRC)
    • 8.1.4. Drug-resistant Neisseria gonorrhoeae (DRNG)
    • 8.1.5. Drug-resistant streptococcus pneumoniae (DRSP)
    • 8.1.6. Methicillin-resistant Staphylococcus aureus (MRSA)
    • 8.1.7. Other pathogen types

9. Antimicrobial Resistance Diagnostics Market - By Technology

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 9.1.2. Immunoassay
    • 9.1.3. Mass spectrometry
    • 9.1.4. Microbiology culture
    • 9.1.5. Next generation sequencing (NGS)
    • 9.1.6. Polymerase chain reaction (PCR)
    • 9.1.7. Rapid & point of care
    • 9.1.8. Other technologies

10. Antimicrobial Resistance Diagnostics Market - By End Use

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End Use, 2024 & 2032 (%)
    • 10.1.2. Diagnostic Laboratories
    • 10.1.3. Hospitals
    • 10.1.4. Pharmaceutical & Biotechnology Companies
    • 10.1.5. Research Institutes
    • 10.1.6. Others

11. Antimicrobial Resistance Diagnostics Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Antimicrobial Resistance Diagnostics Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Antimicrobial Resistance Diagnostics Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Antimicrobial Resistance Diagnostics Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Antimicrobial Resistance Diagnostics Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Antimicrobial Resistance Diagnostics Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Pathogen Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Antimicrobial Resistance Diagnostics Industry

  • 12.1. Competitive Benchmarking
    • 12.1.1. Competitive Dashboard
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Abbott Laboratories
    • 12.2.2. Accelerated Diagnostics, USA
    • 12.2.3. Alifax
    • 12.2.4. BD
    • 12.2.5. Beckman Coulter
    • 12.2.6. Becton, Dickinson and Company
    • 12.2.7. BioMerieux
    • 12.2.8. Bio-Rad Laboratories
    • 12.2.9. Danaher
    • 12.2.10. F. Hoffmann-La Roche
    • 12.2.11. GeneFluidics
    • 12.2.12. Hologic, Inc.
    • 12.2.13. Molsid
    • 12.2.14. OpGen
    • 12.2.15. Roche Diagnostics
    • 12.2.16. Thermo Fisher Scientific
    • 12.2.17. Vela Diagnostics
    • 12.2.18. Visby Medical, Inc.
    • 12.2.19. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us